Monte Rosa Therapeutics, Inc. (GLUE) reported Q1 Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: GLUE) | Delayed: 10.67 +0.01 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.66 | 52 Week High | $ | |||
| Open | $10.51 | 52 Week Low | $ | |||
| Day High | $10.67 | P/E | N/A | |||
| Day Low | $10.40 | EPS | $ | |||
| Volume | 18,866 | |||||
